Transplantační medicína

Explore evidence-based approaches to hypertension diagnosis and treatment for healthcare professionals. Learn how single-pill combinations support blood pressure control through dual and triple combination therapy, aligned with 2023 ESH guidelines.

Explore clinical trial evidence and real-world data on single-pill combination therapy for hypertension. Discover how dual combination therapy improves adherence, persistence, blood pressure control, and cardiovascular outcomes, aligned with 2023 ESH guidelines for healthcare professionals.

Explore clinical strategies for managing hypertension and coronary artery disease in young patients. Discover how single-pill combination therapy, dual and triple combinations, and cardiovascular risk stratification support optimal blood pressure control, aligned with 2023 ESH guidelines for healthcare professionals.

Az orrpolipokkal járó krónikus orrmelléküreg-gyulladás(CRSwNP) egy 2-es típusú gyulladásos folyamat által kiváltott betegség, amely a hatékony kezelések alkalmazása ellenére is hajlamos a visszatérésre.^1–5 
A 2-es típusú gyulladás hátterének, kiváltó tényezőinek, valamint a rendelkezésre álló kezelési lehetőségek – köztük a dupilumab hatóanyagon alapuló biológiai terápia – alapos megismerése hozzájárulhat a betegség hatékonyabb kontrolljához és a kiújulás megelőzéséhez, ezáltal jelentősen javítva a CRSwNP-ben szenvedő betegek terápiás kimenetelét.^1–7

The Type 1 Diabetes (T1D) field is evolving.

Recognition of the presymptomatic stages in T1D is growing.^1-4 

The clinical benefits of early detection of T1D are being highlighted.^3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.^1,2

The Type 1 Diabetes (T1D) field is evolving.

Recognition of the presymptomatic stages in T1D is growing.^1-4 

The clinical benefits of early detection of T1D are being highlighted.^3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.^1,2

The Type 1 Diabetes (T1D) field is evolving.

Recognition of the presymptomatic stages in T1D is growing.^1-4 

The clinical benefits of early detection of T1D are being highlighted.^3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.^1,2